| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.2 | 0.002 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.15 | 0.006 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.14 | 0.008 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.11 | 0.06 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.083 | 0.2 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.073 | 0.2 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.069 | 0.2 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.058 | 0.3 |